Pidilite Industries Ltd
NSE: PIDILITINDCompany page on Cofacto
Open the Pidilite Industries Ltd page

Pidilite Industries Q2 FY27 Earnings Call: Guides 20-24% EBITDA Margin Corridor, Double-Digit Volume Streak Sustained (PIDILITIND)

Cofacto Research Published October 29, 2026 8 min read

Pidilite Industries Ltd held its Q2 FY27 earnings call on October 28, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Strong Top Line, Sharp Input-Cost Squeeze

  • Standalone revenue just under Rs.4,000 crore, up 21.7% YoY — underpinned by underlying volume growth (UVG) of 10.7% in Q2 FY 2026-2027, broad-based across consumer & bazaar and B2B.
  • Segment UVG split — consumer & bazaar at 11.1% and B2B at 9.2% in Q2 FY 2026-2027.
  • Gross margin declined 720 bps (sequentially and YoY) and EBITDA margin fell 430 bps to 20.4% in Q2 FY 2026-2027, at the lower end of the company's range, on elevated input costs.
  • VAM consumption rate hit $1,630 in Q2 FY 2026-2027 — nearly double the year-ago level (Q2 FY 2025-2026) and up from $1,370 in Q1 FY 2026-2027, reflecting the full-quarter impact of input inflation.
  • H1 FY 2026-2027 revenue grew 22% with UVG of 11% (consumer & bazaar 11.6%, B2B 8.3%); H1 EBITDA margin of 23.5% was at the upper end of the range — management stated H1 is a better representation of performance, as Q1 benefited from low-cost inventory while Q2 absorbed the full input cost impact.
  • Meena (waterproofing) was the only business with revenue headwinds in Q2 FY 2026-2027, due to inadequate work front availability.

International and Domestic Subsidiaries Both Compounding Above 20%

  • International subsidiaries grew 21.8% in Q2 FY 2026-2027 — Dubai, Bangladesh, Kenya and Thailand each grew in excess of 20%; international EBITDA grew 53% versus top line growth of 21.8%.
  • Domestic subsidiaries delivered 22.2% revenue growth in Q2 FY 2026-2027, with consumer & bazaar and B2B each growing ~22% and margins holding up well; all except Nina (monsoon-related headwinds) grew north of 20%.
  • ECA (wood finish), the largest consumer & bazaar subsidiary, had a good quarter on volumes and top line (Kavinder Singh, Joint MD).
  • Construction chemicals subsidiaries gained strong traction via the JV route — epoxy grout, marble & stone finish, and waterproofing including the new Wonderproof — driving domestic subsidiary top line and margin improvement.
  • Exports out of India into West Asia, or shipped through West Asia, continue to underperform due to challenges in that region (status as of Q2 FY 2026-2027).

Calibrated Pricing Against a Volatile Cost Curve

  • VAM trajectory — averaged ~$800–900 through FY 2025-2026, spiked to ~$2,000 after the West Asia conflict, cooled to ~$1,000 (some consignments ~$900) entering Q2 FY 2026-2027, and currently stands at ~$1,200; crude is elevated at ~$115 with broad raw-material inflation beyond VAM, and the conflict continues to challenge cargo movement.
  • Pricing actions — proactive replacement-cost pricing in Q1 FY 2026-2027, rebates in Q2 FY 2026-2027 as VAM cooled, one round of increases on Fevicol and Dr. Fixit effective October 1 (Q3 FY 2026-2027), and possibly another towards end-Q3 FY 2026-2027 or early Q4 FY 2026-2027 depending on conditions.
  • 12-15% first-round price increases were taken in Q1 FY 2026-2027 (two staggered phases) in very high-inflation categories; a further 3-5% increase is being taken in October (Q3 FY 2026-2027) in areas of heightened inflation, varying by product, brand and category.
  • Cost pass-through math — CFO Sandeep Batra said the entire cost increase has been passed on in absolute terms ("and more") as of Q2 FY 2026-2027, but at a 50% gross margin, holding the same percentage margin requires pricing in ~2x the cost increase — "not something that can be done overnight."
  • H2 FY 2026-2027 margin guidance — management remains confident of EBITDA margin within the 20-24% corridor, ideally at the slightly higher end, with high confidence on Q3 FY 2026-2027; Q1 FY 2026-2027's 26.3% was an upside surprise aided by low-cost inventory carried from Q4 FY 2025-2026.
  • Margin corridor philosophy — management guided to keeping the 20-24% corridor (period unspecified), intending to stay at the higher end and inch margins up gradually, but stated the margin base cannot be fundamentally reset; pushing margins too high could compromise the India growth opportunity and open segments to competitors. On a hypothetical 20-30% crude/raw-material fall over the next 3-5 years (analyst Tejas Shah, Avendus Park), management responded the existing corridor remains the right profile.
  • Pricing philosophy — management will not transmit month-to-month volatility to the market and will manage pricing for full-year FY 2026-2027, pricing on consumption/replacement margin over carried inventory, unlike local competitors with single/spot-price margins and minimal inventory.

Urban Uptick, Double-Digit Volume Streak

  • Double-digit UVG sustained for ~6-8 quarters through Q2 FY 2026-2027 (MD Sudhanshu Vats); the Jefferies analyst noted double-digit growth in 8 of the last 10 quarters despite Middle East-driven uncertainty, with growth ahead of peers.
  • Urban growth slightly ahead of rural in Q2 FY 2026-2027 for the first time in a long time — urban demand has seen an uptick while rural holds at existing levels (Kavinder Singh).
  • Construction chemicals momentum — Dr. Fixit, Roff tile adhesives, grouts and Tinex stone care delivering robust growth, with momentum beginning in floor coatings, across urban and emerging India markets; Pidilite is growing above the tile adhesive category and is determined to gain share.
  • Projects business reorganized — approach shifted to a segment-based model targeting medium and large builders (residential, commercial) plus hotels, hospitals, education institutions and EPC contractors; sales teams were reorganized in Q2 FY 2026-2027, with benefits expected to play out in Q3 FY 2026-2027.
  • FY 2026-2027 demand outlook — management expects UVG to remain double-digit if India's real GDP growth stays in the 6.5-7% range; demand is "reasonably robust" and the company entered Q3 FY 2026-2027 "quite well". Not fully baked in: the latest pricing round, El Nino, elevated crude (if it persists) and a potential further West Asia flare-up.
  • No macro improvement assumed for the remainder of FY 2026-2027 — management is treating ongoing conflicts, elevated crude and recurring supply chain disruptions as "the new macro," while remaining focused on double-digit UVG in FY 2026-2027.

Pioneer Categories, Grupo Puma Renders, Premiumization

  • ~10-20 pioneering categories in work at any time (MD Sudhanshu Vats); the Grupo Puma JV (external renders) has completed 6-7 pilots in North India with good success and is working on large projects.
  • Renders TAM — management cited Southern Europe, where external renders can be 15-20% of all conventional (non-glass-and-steel) exterior walls, as a very large TAM if India reaches similar levels; timing and extent of play-out remain uncertain (period unspecified).
  • Renders rollout — the technology (with Spanish JV partner Grupo Puma) delivers 15-20 years of waterproofing with aesthetically strong facades; focus is on projects (commercial buildings, hotels, low-rise residential), rollout underway in FY 2026-2027, and management is evaluating additional render production plants beyond the current Rajasthan facility.
  • Grupo Puma partnership extended to tile adhesives — Neopro launched in the premium/specialized range and gaining good momentum; partner-led technology sourcing is positioned as an early-mover moat.
  • Innovation slate in FY 2026-2027 — Araldite White X and Wood X (new-to-portfolio premium products); Fevicol-piloted Multilock and Expert go national in November 2026 (Q3 FY 2026-2027); Dr. Fixit Wonderlock performing well; M Seal Advanced in pilot (easy wash-off, universal application, low VOC/solvent); Wonderproof enables pre- and post-coat application; a newly launched spin-off is seeing strong quick-commerce response.
  • B2B vectors and portfolio transitions — partnerships pursued across electronics sub-segments, opportunity in auto/EV, and footwear adhesives flagged as promising as multiple footwear companies look to set up manufacturing in India with approved projects (industry context); eka Pidilite has moved from pioneer to a clear growth category, and work is underway on wall finishes after wood finishes.
  • Core growth via premiumization — premiumization in Fevicol and feature-led products in Dr. Fixit and M-Seal, plus premiumization in the consumer space.

Effectiveness First, Productivity Later; UVG Ambition Intact

  • AI journey status (Q2 FY 2026-2027) — the top 30 leaders completed a one-day hands-on AI workshop (including coding); company-wide AI hackathons are underway, the first done and the second upcoming (Sudhanshu Vats); agentic AI is being explored in HR, assessments and finance.
  • Phase 1 focus is effectiveness, not cost — customized offerings, all-language editing, short-form content, influencer management, rapid AI copy adaptation and AI-led analytics for range selling; productivity gains and manpower reduction are explicitly deferred to a "phase two" with no timeline (period unspecified), and management gave no quantified operating-leverage guidance on employee or A&P costs for the "next couple of years" horizon asked by Jay Doshi (Kotak Securities).
  • Manufacturing/supply-chain AI — improving material variances in manufacturing; supply-chain use cases under development for reduced response times and network optimization; automation is aimed at consistent quality rather than staff-cost reduction (Kavinder Singh).
  • Staff-cost stance — staff cost is "not an objective by itself"; operating leverage is already in play and will "probably" see more as initiatives enable growth with limited manpower additions — the goal in the current growth phase is a more effective workforce, not headcount reduction.
  • UVG actuals and trajectory — H1 FY 2025-2026 UVG was 10.1% vs 11% in H1 FY 2026-2027 (ED & CFO Sandeep Batra); over the last 3-4 years through H1 FY 2026-2027, UVG has inched up ~60 bps, 70 bps and 100 bps annually.
  • UVG outlook — for FY 2026-2027, management would like to deliver double-digit UVG but said that with significant inflation this year it is not the right time to discuss raising the target; over the medium term (period unspecified), the desire is to lift UVG from classic double-digit to early teens. Management is committed to profitable underlying volume growth and not chasing volume for volume's sake.
  • CFO transition watch — Amit Agarwal appeared on the call as CFO designate alongside incumbent ED & CFO Sandeep Batra; no transition timeline was stated.
Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now